US Stock MarketDetailed Quotes

TMDX TransMedics

Watchlist
  • 66.005
  • -1.355-2.01%
Trading Dec 12 12:12 ET
2.22BMarket Cap70.97P/E (TTM)

TransMedics Key Stats

TransMedics Q3 2024 Earnings Date

Currency:USDOct 28, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
115.00M
108.76M
-6.24M
Miss Est.
+73.11%
+63.72%
-5.42%
EPS
0.31
0.12
-0.19
Miss Est.
+140.30%
+115.38%
-61.82%
Buy

Dec 12, 2024

TransMedics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 120.199M--
--2024/Q4-- / 109.620M--
Oct 28, 20242024/Q3108.761M / 114.997M--
--2024/Q2114.305M / 98.957M--
Apr 30, 20242024/Q196.850M / 83.608M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 120.199M--
--2024/Q4-- / 109.620M--
Oct 28, 20242024/Q3108.761M / 114.997M--
--2024/Q2114.305M / 98.957M--
Apr 30, 20242024/Q196.850M / 83.608M--

Unlock Free Earnings Estimates

TransMedics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 12, 2024

Buy

  • Buy

    71.43%
  • Hold

    28.57%
  • Sell

    0.00%

Price Target

No Data